Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer
Clinical trial NCT05702424 · COMPLETED
Trial details
- NCT number
- NCT05702424
- Sponsor
- IGM Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2024-05-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.